Expression of concern
From the Cyclooxygenase-2 Inhibitor Celecoxib to a Novel Class of 3-Phosphoinositide-Dependent Protein Kinase-1 Inhibitors
Paper Information
Record ID:
20220
Author(s):
Journal:
Publication Date:
June 15, 2004
Retraction Date:
April 01, 2019
(6.6 years years ago)
Subjects:
Institution:
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OhioCountry:
🇺🇸 United StatesArticle Type:
Publisher:
American Association for Cancer Research
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1158/0008-5472.CAN-19-0502Additional Notes:
Ching Shih Chen has institutional misconduct finding;
Citations (239)
239
Total Citations23
Post-Retraction(9.6%)
196
Pre-Retraction1
Same DayPost-Retraction Citation Analysis
1
Within 30 days
4
Within 1 year
16
After 2+ years
2102
Days since retraction (latest)
Targeting PDK1 for Chemosensitization of Cancer Cells
Aikaterini Emmanouilidi, Marco Falasca
Cancers
Open Access
Published: Oct 2017
55 citations
55 citations
524 days before retraction
Role of the unfolded protein response in determining the fate of tumor cells and the promise of multi-targeted therapies
Kunyu Shen, David W. Johnson, David A. Vesey et al. (5 authors)
Cell Stress and Chaperones
Open Access
Published: Sep 2017
21 citations
21 citations
551 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Sep 2017
577 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Aug 2017
586 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Aug 2017
594 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jun 2017
669 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Mar 2017
761 days before retraction
Candidate novel long noncoding RNAs, MicroRNAs and putative drugs for Parkinson's disease using a robust and efficient genome-wide association study
Zahra Mortezaei, Hossein Lanjanian, Ali Masoudi‐Nejad
Genomics
Published: Feb 2017
25 citations
25 citations
768 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jan 2017
820 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Dec 2016
851 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Nov 2016
873 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jul 2016
985 days before retraction
AR‐12 Inhibits Multiple Chaperones Concomitant With Stimulating Autophagosome Formation Collectively Preventing Virus Replication
Laurence Booth, Jane L. Roberts, Heath Ecroyd et al. (16 authors)
Journal of Cellular Physiology
Open Access
Published: May 2016
43 citations
43 citations
1049 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Apr 2016
1095 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Mar 2016
1125 days before retraction
Paper citing Regulation of OSU-03012 Toxicity by ER Stress Prot...
Unknown Authors
Unknown Journal
Published: Feb 2016
1144 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Sep 2015
1281 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Sep 2015
1281 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Aug 2015
1339 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Aug 2015
1339 days before retraction
Paper citing Regulation of OSU-03012 Toxicity by ER Stress Prot...
Unknown Authors
Unknown Journal
Published: Jun 2015
1378 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: May 2015
1431 days before retraction
Paper citing Regulation of OSU-03012 Toxicity by ER Stress Prot...
Unknown Authors
Unknown Journal
Published: Apr 2015
1435 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Apr 2015
1452 days before retraction
Paper citing Regulation of OSU-03012 Toxicity by ER Stress Prot...
Unknown Authors
Unknown Journal
Published: Mar 2015
1466 days before retraction
Paper citing Regulation of OSU-03012 Toxicity by ER Stress Prot...
Unknown Authors
Unknown Journal
Published: Mar 2015
1492 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jan 2015
1538 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jan 2015
1551 days before retraction
Paper citing Sensitizing Estrogen Receptor–negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Dec 2014
1579 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Dec 2014
1582 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Nov 2014
1587 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Oct 2014
1643 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Oct 2014
1643 days before retraction
Paper citing Sensitizing Estrogen Receptor–negative Breast Canc...
Unknown Authors
Unknown Journal
Published: Sep 2014
1664 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jul 2014
1705 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jul 2014
1712 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jul 2014
1725 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jun 2014
1765 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: May 2014
1772 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Apr 2014
1826 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Mar 2014
1857 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Dec 2013
1947 days before retraction
RAC1: An Emerging Therapeutic Option for Targeting Cancer Angiogenesis and Metastasis
Hemant K. Bid, Ryan D. Roberts, Parmeet K. Manchanda et al. (4 authors)
Molecular Cancer Therapeutics
Open Access
Published: Sep 2013
244 citations
244 citations
2012 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Sep 2013
2014 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Aug 2013
2069 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Jul 2013
2072 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: May 2013
2146 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: May 2013
2161 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: May 2013
2161 days before retraction
Paper citing From the Cyclooxygenase-2 Inhibitor Celecoxib to a...
Unknown Authors
Unknown Journal
Published: Mar 2013
2208 days before retraction
Quick Stats
Total Citations:
239
Years Since Retraction:
6.6 years
Open Access:
Yes
Last Checked:
Never